secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2026-06-23T12:35:48+00:00
Accession:  0001628280-26-044806
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx stockholders elect Katherine Stueland as Class II director, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Katherine Stueland elected Class II director: 18,325,894 for, 5,893,466 withheld, 3,409,327 broker non-votes.
- Ernst & Young ratified as independent auditor for FY2026: 27,466,639 for, 158,884 against.
- Advisory vote on executive compensation approved: 22,705,946 for, 1,471,593 against.
- Future say-on-pay frequency set at every 1 year: 23,816,121 votes for 1 year (majority).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000162828026044806/0001628280-26-044806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000162828026044806/wgs-20260618.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-044806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer